scholarly journals Next-generation sequencing is a credible strategy for blood group genotyping

2014 ◽  
Vol 167 (4) ◽  
pp. 554-562 ◽  
Author(s):  
Yann Fichou ◽  
Marie-Pierre Audrézet ◽  
Paul Guéguen ◽  
Cédric Le Maréchal ◽  
Claude Férec
Keyword(s):  
Next Generation Sequencing ◽  
Blood Group ◽  
Next Generation ◽  
Generation Sequencing

scholarly journals Next-Generation Sequencing Technologies in Blood Group Typing

2019 ◽  
Vol 47 (1) ◽  
pp. 4-13 ◽  
Author(s):  
Daniel Fürst ◽  
Chrysanthi Tsamadou ◽  
Christine Neuchel ◽  
Hubert Schrezenmeier ◽  
Joannis Mytilineos ◽  
...  
Keyword(s):  
Next Generation Sequencing ◽  
Blood Group ◽  
Large Scale ◽  
Cost Effective ◽  
Molecular Testing ◽  
Blood Group Antigens ◽  
Next Generation ◽  
Sequencing Technologies ◽  
Blood Group Typing ◽  
Generation Sequencing

Sequencing of the human genome has led to the definition of the genes for most of the relevant blood group systems, and the polymorphisms responsible for most of the clinically relevant blood group antigens are characterized. Molecular blood group typing is used in situations where erythrocytes are not available or where serological testing was inconclusive or not possible due to the lack of antisera. Also, molecular testing may be more cost-effective in certain situations. Molecular typing approaches are mostly based on either PCR with specific primers, DNA hybridization, or DNA sequencing. Particularly the transition of sequencing techniques from Sanger-based sequencing to next-generation sequencing (NGS) technologies has led to exciting new possibilities in blood group genotyping. We describe briefly the currently available NGS platforms and their specifications, depict the genetic background of blood group polymorphisms, and discuss applications for NGS approaches in immunohematology. As an example, we delineate a protocol for large-scale donor blood group screening established and in use at our institution. Furthermore, we discuss technical challenges and limitations as well as the prospect for future developments, including long-read sequencing technologies.

P090 Development of a next generation sequencing based ABO blood group assay and typing software

2017 ◽  
Vol 78 ◽  
pp. 120
Author(s):  
William J. Lane ◽  
Helen Mah ◽  
John Baronas ◽  
Abigail Joseph ◽  
Judith Aeschlimann ◽  
...  
Keyword(s):  
Next Generation Sequencing ◽  
Blood Group ◽  
Abo Blood Group ◽  
Next Generation ◽  
Generation Sequencing

Next-generation sequencing: academic overkill or high-resolution routine blood group genotyping?

2015 ◽  
Vol 10 (S1) ◽  
pp. 250-256 ◽  
Author(s):  
N. D. Avent ◽  
T. E. Madgett ◽  
A. J. Halawani ◽  
M. A. Altayar ◽  
M. Kiernan ◽  
...  
Keyword(s):  
Next Generation Sequencing ◽  
High Resolution ◽  
Blood Group ◽  
Next Generation ◽  
Routine Blood ◽  
Generation Sequencing

The use of next-generation sequencing for the determination of rare blood group genotypes

2017 ◽  
Vol 29 (3) ◽  
pp. 162-168 ◽  
Author(s):  
M. A. Jakobsen ◽  
C. Dellgren ◽  
C. Sheppard ◽  
M. Yazer ◽  
U. Sprogøe
Keyword(s):  
Next Generation Sequencing ◽  
Blood Group ◽  
Next Generation ◽  
Generation Sequencing

Extended Blood Group Molecular Typing and Next-Generation Sequencing

2014 ◽  
Vol 28 (4) ◽  
pp. 177-186 ◽  
Author(s):  
Zhugong Liu ◽  
Meihong Liu ◽  
Teresita Mercado ◽  
Orieji Illoh ◽  
Richard Davey
Keyword(s):  
Next Generation Sequencing ◽  
Blood Group ◽  
Molecular Typing ◽  
Next Generation ◽  
Generation Sequencing

scholarly journals Prediction of Extended Red Blood Cell Phenotype from Exome Next Generation Sequencing Data

Blood ◽  
2017 ◽  
Vol 130 (Suppl_1) ◽  
pp. 705-705
Author(s):  
Celina Montemayor Garcia ◽  
Spencer E Grissom ◽  
Oscar A Montemayor ◽  
Katie L Lewis ◽  
Panagiota Karagianni ◽  
...  
Keyword(s):  
Next Generation Sequencing ◽  
Blood Cell ◽  
Open Source ◽  
Blood Group ◽  
Red Blood Cell ◽  
African Ancestry ◽  
Ethnic Composition ◽  
Cell Phenotype ◽  
Next Generation ◽  
Generation Sequencing

Abstract Introduction: Accurate typing of patient and donor red blood cell (RBC) antigens is critical for safe transfusion practice. Although blood typing is traditionally accomplished by serology, genotyping methods to predict RBC antigens have proven valuable in a growing number of situations such as recently-transfused patients, scarcity of typing reagents, and indeterminate serologic results. However current RBC genotyping assays address a limited number of blood group genes and associated variants, and may not detect novel genetic changes and certain rare but clinically-significant variants. Next generation sequencing (NGS) technology provides an appealing alternative technology, allowing the user to examine a patient's entire genome or exome in a high-throughput manner. Whereas efforts are underway in multiple fields to apply exome sequencing (ES) for diagnostic, prognostic, and treatment purposes, Transfusion Medicine, with its extensive clinical genomic database, should find ready application from this approach. We describe here the creation of an algorithm to interpret NGS into a predicted extended RBC phenotype, and its application to analyze ES data from 245 participants of the ClinSeq® sequencing cohort. Methods: RyLAN (Red Cell and Lymphocyte Antigen prediction from NGS) was created as an open-source Python application that takes an NGS sorted binary alignment matrix (.bam) file and index as input. The software interacts with a non-relational database that encodes genomic blood group coordinates and phenotype interpretation rules, and yields a predicted extended RBC phenotype and quality parameters. Hard filters for mapping quality, depth, vcf QUAL, and fraction of alternate allele can be modified per individual genomic coordinate. The output is provided as a MongoDB document to facilitate advanced bulk queries and statistical analysis. We employed RyLAN to analyze 245 ES NGS files from the ClinSeq® cohort, using a database of 176 known antigenic, null, and weak blood group single nucleotide variants in 27 blood group genes as input. Results: The cohort consisted of 115 females and 130 males; 89% of participants self-described as white race, non- Hispanic ethnicity. Three percent of participants self-described as Hispanic or Latino, 4% as Asian, 2% with African ancestry, and the remaining as mixed or unknown race. From the total 176 genomic positions analyzed, 160 were not addressed by current commercially-available RBC genotyping platforms. The average read depth for the positions of interest was 78.2, and the average vcf QUAL value was 968. The highest variant nucleotide frequency was observed at the Fya/Fyb and Jka/Jkb loci (275 and 223 total haplotype variant calls, respectively). Among other phenotypes, RyLAN predicted 4 instances of heterozygosity for the KEL*02N.17 allele, 5 heterozygous individuals for the weak FY* X allele, 32 total heterozygous samples for various weak Kidd alleles, 2 homozygous individuals for weak Kidd expression, 1 heterozygosity for Lu6/Lu9, 1 SC:1,2 case, 1 Co(a-b+) predicted phenotype, and a total of 19 RHAG*01.04 and 47 KLF1*BGM12 alleles. Limited areas of the BCAM, KLF1, KEL, FUT7, ERMAP and CR1 genes failed quality filters repeatedly, and careful review indicated that these regions were not captured in the ES libraries. The ACKR1 promoter GATA-binding site variant was present in every sample and predicted all cases of self-reported African ancestry. Conclusions: We describe a new, open-source informatics tool to translate NGS data into a predicted extended RBC phenotype, and demonstrate its application through the analysis of 245 ClinSeq® ES files. Most predicted antigen frequencies were as expected for the ethnic composition of our cohort. We detected a higher frequency of the RHAG p.V270I and KLF1 p.S102P variants than expected, findings that are in agreement with the 1000 Genomes Project and warrant further study. Our analysis also corroborates the relative frequency of the JK*01W.01 allele, and the presence of the JK*01W.03 and JK*01W.04 alleles in the Caucasian population, which can lead to serologic discrepancies in other genotyping platforms. Serologic confirmation of these findings is being conducted. Further study of genomic data across multiple ethnic groups can help refine knowledge of blood group gene polymorphisms and their clinical association. Disclosures No relevant conflicts of interest to declare.

Sign in / Sign up

Export Citation Format

Share Document